
																
																	Intravitreal administration of endothelin type A receptor or endothelin type B receptor antagonists attenuates hypertensive and diabetic retinopathy in rats
																
																
																
															Keywords: Endothelin; Diabetes; Diabetic retinopathy; Retinal pigment epithelium; Hypertension; Vascular leakage; VEGF; BRB; blood-retinal barrier; BQ123; endothelin type A receptor antagonist; BQ788; endothelin type B receptor antagonist; Diab; diabetic; ET-1; end